FDA-Drug2024-05-29Class III
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
Hazard
Failed Release Testing: Out of specification for particulate matter test.
Sold states
TX, PA
Affected count
35,069 bottles
Manufactured in
2 Independence Way, Princeton, NJ, United States
Products
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0502-2024More SUN PHARMACEUTICAL INDUSTRIES INC recalls
- FDA-Drug2026-06-17Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles
- FDA-Drug2026-06-17Sun Pharmaceutical doxorubicin injection recalled for glass particles
- FDA-Drug2026-04-22Taro Fluocinonide 0.05% Cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide cream recalled for failed viscosity specifications
- FDA-Drug2026-04-22Taro Pharmaceuticals fluocinonide 0.05% cream recalled for viscosity defect
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief